Xeriant, Inc.
XERI
$0.0151
$0.00085.59%
| Weiss Ratings | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.63 | |||
| Price History | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.03% | |||
| 30-Day Total Return | -11.18% | |||
| 60-Day Total Return | -2.58% | |||
| 90-Day Total Return | 19.84% | |||
| Year to Date Total Return | -13.22% | |||
| 1-Year Total Return | -9.58% | |||
| 2-Year Total Return | -49.50% | |||
| 3-Year Total Return | -87.29% | |||
| 5-Year Total Return | -35.19% | |||
| 52-Week High % Change | -62.16% | |||
| 52-Week Low % Change | 51.00% | |||
| Price | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.04 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Nov 01, 2024 | |||
| 52-Week High Price (Date) | May 16, 2024 | |||
| Valuation | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 9.94M | |||
| Enterprise Value | 14.82M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -35.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -1.57 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -7.64 | |||
| Enterprise Value/EBIT | -7.63 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 596.20M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 561 491 9595 | |||
| Address | Innovation Centre 1 Boca Raton, FL 33431 | |||
| Website | www.xeriant.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -598.34% | |||
| Return on Equity | -- | |||
| Income Statement | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -1.94M | |||
| EBIT (TTM) | -1.94M | |||
| Net Income (TTM) | -2.31M | |||
| Net Income Avl. to Common (TTM) | -2.31M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 65.42% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 75.00% | |||
| Balance Sheet | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 254.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 268.60K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -8.69M | |||
| Current Ratio (Q) | 0.030 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 276.60K | |||
| Total Current Liabilities (Q) | 8.97M | |||
| Total Debt (Q) | 8.00M | |||
| Total Liabilities (Q) | 8.97M | |||
| Total Common Equity (Q) | -5.82M | |||
| Cash Flow | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 1.75M | |||
| Net Change in Cash (TTM) | 215.20K | |||
| Levered Free Cash Flow (TTM) | -1.00M | |||
| Cash from Operations (TTM) | -1.54M | |||
